Photodynamic antimicrobial chemotherapy (PACT) using riboflavin inhibits the mono and dual species biofilm produced by antibiotic resistant Staphylococcus aureus and Escherichia coli
Authors:
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 32, 102002
Abstract
No abstract availableKeywords
Funding Information
- Department of Biotechnology, Government of West Bengal
This publication has 47 references indexed in Scilit:
- Riboflavin as a photosensitizer. Effects on human health and food qualityFood & Function, 2012
- Polymicrobial Interactions: Impact on Pathogenesis and Human DiseaseClinical Microbiology Reviews, 2012
- Screening of Escherichia coli Species Biodiversity Reveals New Biofilm-Associated Antiadhesion PolysaccharidesmBio, 2011
- Susceptibility of Candida albicans, Staphylococcus aureus, and Streptococcus mutans biofilms to photodynamic inactivation: an in vitro studyLasers in Medical Science, 2010
- Improvement of Multiple-Stress Tolerance and Lactic Acid Production inLactococcus lactisNZ9000 under Conditions of Thermal Stress by Heterologous Expression ofEscherichia coli dnaKApplied and Environmental Microbiology, 2010
- Antimicrobial Photodynamic Therapy: Study of Bacterial Recovery Viability and Potential Development of Resistance after TreatmentMarine Drugs, 2010
- Photodynamic therapy for localized infections—State of the artPhotodiagnosis and Photodynamic Therapy, 2009
- The Diverse Roles of Flavin CoenzymesNature's Most Versatile ThespiansThe Journal of Organic Chemistry, 2007
- An in vitro biofilm model of subgingival plaqueOral Microbiology and Immunology, 2007
- Singlet Oxygen Generation by UVA Light Exposure of Endogenous PhotosensitizersBiophysical Journal, 2006